Kim J - Search Results

1

Pan-Pim Kinase Inhibitor AZD1208 Suppresses Tumor Growth and Synergistically Interacts with Akt Inhibition in Gastric Cancer Cells.

Lee M, Lee KH, Min A, Kim J, Kim S, Jang H, Lim JM, Kim SH, Ha DH, Jeong WJ, Suh KJ, Yang YW, Kim TY, Oh DY, Bang YJ, Im SA. Lee M, et al. Among authors: kim sh, kim ty, kim s, kim j. Cancer Res Treat. 2019 Apr;51(2):451-463. doi: 10.4143/crt.2017.341. Epub 2018 Jun 6. Cancer Res Treat. 2019. PMID: 29879757 Free PMC article.

2

Efficacy and safety of docetaxel plus prednisolone chemotherapy for metastatic hormone-refractory prostate adenocarcinoma: single institutional study in Korea.

Lee JL, Kim JE, Ahn JH, Lee DH, Lee J, Kim CS, Hong JH, Hong B, Song C, Ahn H. Lee JL, et al. Among authors: kim cs, kim je. Cancer Res Treat. 2010 Mar;42(1):12-7. doi: 10.4143/crt.2010.42.1.12. Epub 2010 Mar 31. Cancer Res Treat. 2010. PMID: 20369046 Free PMC article.

3

Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: a phase III trial of the Korean Cancer Study Group (KCSG-BR06-01).

Kim JE, Ahn JH, Jung KH, Kim SB, Kim HJ, Lee KS, Ro JS, Park YH, Ahn JS, Im YH, Im SA, Lee MH, Kim SY. Kim JE, et al. Breast Cancer Res Treat. 2011 Jan;125(1):99-106. doi: 10.1007/s10549-010-1201-8. Epub 2010 Oct 5. Breast Cancer Res Treat. 2011. PMID: 20922564 Clinical Trial.

4

Bcl-2 as a predictive factor for biochemical recurrence after radical prostatectomy: an interim analysis.

Cho IC, Chung HS, Cho KS, Kim JE, Joung JY, Seo HK, Chung J, Park WS, Hong EK, Lee KH. Cho IC, et al. Among authors: kim je. Cancer Res Treat. 2010 Sep;42(3):157-62. doi: 10.4143/crt.2010.42.3.157. Epub 2010 Sep 30. Cancer Res Treat. 2010. PMID: 20948921 Free PMC article.

5

NVP-BEZ235, a dual PI3K/mTOR inhibitor, induces cell death through alternate routes in prostate cancer cells depending on the PTEN genotype.

Hong SW, Shin JS, Moon JH, Kim YS, Lee J, Choi EK, Ha SH, Lee DH, Chung HN, Kim JE, Kim KP, Hong YS, Lee JL, Lee WJ, Choi EK, Lee JS, Jin DH, Kim TW. Hong SW, et al. Among authors: kim tw, kim kp, kim ys, kim je. Apoptosis. 2014 May;19(5):895-904. doi: 10.1007/s10495-014-0973-4. Apoptosis. 2014. PMID: 24652480

6

Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal Cancer.

Kim KP, Kim JE, Hong YS, Ahn SM, Chun SM, Hong SM, Jang SJ, Yu CS, Kim JC, Kim TW. Kim KP, et al. Cancer Res Treat. 2017 Jan;49(1):161-167. doi: 10.4143/crt.2015.490. Epub 2016 Jul 4. Cancer Res Treat. 2017. PMID: 27384156 Free PMC article.

7

Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline.

Sohn BS, Kim SB, Ahn JH, Jung KH, Kim J, Lee KS, Ro J, Im SA, Im YH, Song HS, Park HS, Chung HC. Sohn BS, et al. Among authors: kim sb, kim j. Asia Pac J Clin Oncol. 2017 Dec;13(6):365-371. doi: 10.1111/ajco.12681. Epub 2017 Mar 16. Asia Pac J Clin Oncol. 2017. PMID: 28303646

8

Impact of Patient Sex on Adverse Events and Unscheduled Utilization of Medical Services in Cancer Patients Undergoing Adjuvant Chemotherapy: A Multicenter Retrospective Cohort Study.

Choi S, Seo S, Lee JH, Suh KJ, Kim JW, Kim JW, Kim SH, Kim YJ, Lee KW, Kim JH, Kim TW, Hong YS, Kim SY, Kim JE, Kim SW, Lee DH, Lee JC, Choi CM, Yoon S, Koh SJ, Min YJ, Ahn Y, Kim HJ, Baek JH, Park SR, Kim JH. Choi S, et al. Cancer Res Treat. 2024 Apr;56(2):404-413. doi: 10.4143/crt.2023.784. Epub 2023 Nov 7. Cancer Res Treat. 2024. PMID: 37933112 Free PMC article.

9

Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid Tumors.

Kang YK, Ryu MH, Hong YS, Choi CM, Kim TW, Ryoo BY, Kim JE, Weis JR, Kingsford R, Park CH, Jang S, McGinn A, Werner TL, Sharma S. Kang YK, et al. Cancer Res Treat. 2024 Jul;56(3):743-750. doi: 10.4143/crt.2023.980. Epub 2024 Jan 18. Cancer Res Treat. 2024. PMID: 38271925 Free PMC article. Clinical Trial.

10

Splicing variants of the orphan G-protein-coupled receptor GPR56 regulate the activity of transcription factors associated with tumorigenesis.

Kim JE, Han JM, Park CR, Shin KJ, Ahn C, Seong JY, Hwang JI. Kim JE, et al. J Cancer Res Clin Oncol. 2010 Jan;136(1):47-53. doi: 10.1007/s00432-009-0635-z. J Cancer Res Clin Oncol. 2010. PMID: 19572147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136,229 results

Search Page

Filters